Vardenafil Tablet, Orally Disintegrating
Product Images NDC 62332-235

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil (NDC 62332-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Vardenafil Fig1)

FDA Label Image

Figure 2 (Vardenafil Fig2)

Figure 2 (Vardenafil Fig2)
This is a graph displaying mean change in mmHg over time for different treatments. The treatments compared are a placebo (Sulareous) versus taking Vadorall 5 mg (Smulaneous) with or without a H Separator. The x-axis represents the time, and the y-axis shows the change in mmHg. There is a significant reduction in mmHg for most treatments compared to the placebo.*
FDA Label Image

Figure 3 (Vardenafil Fig3)

FDA Label Image

Figure 4 (Vardenafil Fig4)

FDA Label Image

Figure 5 (Vardenafil Fig5)

FDA Label Image

Figure 6 (Vardenafil Fig6)

FDA Label Image

Figure 7 (Vardenafil Fig7)

FDA Label Image

Figure 8 (Vardenafil Fig8)

FDA Label Image

Vardenafil HCl Odt mg 10

FDA Label Image

Structure (Vardenafil Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.